Overview
Safety \& Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) versus Loperamide for the Treatment of Low Anterior Resection Syndrome (RALLARS): Multicenter Randomized Controlled Trial
Eligibility
Inclusion Criteria:
- mid and low rectal cancer (AV\<15cm)
- stage II, III, preop long-course CCRT, then ileostomy repair
- about 1\~12 months after operation (no stomy)
- about 1\~6 months after ileostomy repair
- major LARS
Exclusion Criteria:
- recurred rectal cancer
- stage IV
- IBD
- uncontrolled preoperative fecal incontinence or constipation


